menu
    • menu

    Company profile for Apellis Pharmaceuticals

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to...
    We are a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad array of complement-dependent autoimmune and inflammatory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apellis PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6400 Westwind Way, Suite A Crestwood, KY 40014
    Telephone
    Telephone
    (502) 241-4114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.apellis.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apellis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ApellisPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apellis Pharma To Discuss 2025 Financial Results In Feb 24 Call
    Apellis Pharma To Discuss 2025 Financial Results In Feb 24 Call

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235166/0/en/Apellis-Pharmaceuticals-to-Host-Conference-Call-on-February-24-2026-to-Discuss-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Ocugen Update Charts Course For Rivalry With Apellis, Astellas
    Ocugen Update Charts Course For Rivalry With Apellis, Astellas

    15 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ocugen-posts-midphase-gene-therapy-data-charting-course-rivalry-apellis-and-astellas

    FIERCE BIOTECH
    15 Jan 2026
    Share Share
    Apellis Reports 4% Sales Drop For Eye Disease Med Syfovre
    Apellis Reports 4% Sales Drop For Eye Disease Med Syfovre

    12 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/apellis-shares-tumble-sales-decline-eye-disease-treatment-syfovre

    FIERCE PHARMA
    12 Jan 2026
    Share Share
    Apellis Pharma Presents At 44Th J.P. Morgan Healthcare Conference
    Apellis Pharma Presents At 44Th J.P. Morgan Healthcare Conference

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212609/0/en/Apellis-Pharmaceuticals-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    NEJM Publishes VALIANT EMPAVELI Results for C3G & Primary IC-MPGN
    NEJM Publishes VALIANT EMPAVELI Results for C3G & Primary IC-MPGN

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3199410/0/en/The-New-England-Journal-of-Medicine-Publishes-Positive-Phase-3-VALIANT-Results-of-EMPAVELI-pegcetacoplan-for-C3G-and-Primary-IC-MPGN.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Apellis Pharma Joins Investor Conferences
    Apellis Pharma Joins Investor Conferences

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194196/0/en/Apellis-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search